Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182


The impact of p16ink4a positivity in invasive vulvar cancer on disease-free and disease-specific survival, a retrospective study.

Gensthaler L, Joura EA, Alemany L, Horvat R, de Sanjosé S, Pils S.

Arch Gynecol Obstet. 2020 Jan 22. doi: 10.1007/s00404-020-05431-7. [Epub ahead of print]


Activity of Pulmonary Vancomycin Exposures versus Planktonic and Biofilm Methicillin-Resistant Staphylococcus aureus Isolated from Cystic Fibrosis Sputum.

Britt NS, Hazlett DS, Horvat RT, Liesman RM, Steed ME.

Int J Antimicrob Agents. 2020 Jan 10:105898. doi: 10.1016/j.ijantimicag.2020.105898. [Epub ahead of print]


Pre-operative hypoalbuminemia is associated with complication rate and overall survival in patients with vulvar cancer undergoing surgery.

Bekos C, Polterauer S, Seebacher V, Bartl T, Joura E, Reinthaller A, Sturdza A, Horvat R, Schwameis R, Grimm C.

Arch Gynecol Obstet. 2019 Oct;300(4):1015-1022. doi: 10.1007/s00404-019-05278-7. Epub 2019 Aug 29.


Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan.

Salk JJ, Loubet-Senear K, Maritschnegg E, Valentine CC, Williams LN, Higgins JE, Horvat R, Vanderstichele A, Nachmanson D, Baker KT, Emond MJ, Loter E, Tretiakova M, Soussi T, Loeb LA, Zeillinger R, Speiser P, Risques RA.

Cell Rep. 2019 Jul 2;28(1):132-144.e3. doi: 10.1016/j.celrep.2019.05.109.


Patient-derived cell line models revealed therapeutic targets and molecular mechanisms underlying disease progression of high grade serous ovarian cancer.

Kreuzinger C, von der Decken I, Wolf A, Gamperl M, Koller J, Karacs J, Pfaffinger S, Bartl T, Reinthaller A, Grimm C, Singer CF, Braicu EI, Cunnea P, Gourley C, Smeets D, Boeckx B, Lambrechts D, Perco P, Horvat R, Berns EMJJ, Cacsire Castillo-Tong D.

Cancer Lett. 2019 Sep 10;459:1-12. doi: 10.1016/j.canlet.2019.05.032. Epub 2019 May 28.


NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer-An Integrative Multi-Omics Approach.

Bekos C, Muqaku B, Dekan S, Horvat R, Polterauer S, Gerner C, Aust S, Pils D.

Cancers (Basel). 2019 May 20;11(5). pii: E698. doi: 10.3390/cancers11050698.


PET Radiopharmaceuticals for Specific Bacteria Imaging: A Systematic Review.

Auletta S, Varani M, Horvat R, Galli F, Signore A, Hess S.

J Clin Med. 2019 Feb 6;8(2). pii: E197. doi: 10.3390/jcm8020197. Review.


The role of tenascin-X in the uterosacral ligaments of postmenopausal women with pelvic organ prolapse: an immunohistochemical study.

Bodner-Adler B, Bodner K, Kimberger O, Halpern K, Schneidinger C, Haslinger P, Schneeberger C, Horvat R, Umek W.

Int Urogynecol J. 2020 Jan;31(1):101-106. doi: 10.1007/s00192-018-3820-2. Epub 2018 Dec 10.


Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis.

Bekos C, Schwameis R, Heinze G, Gärner M, Grimm C, Joura E, Horvat R, Polterauer S, Polterauer M.

Sci Rep. 2018 Apr 23;8(1):6383. doi: 10.1038/s41598-018-24882-2.


A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer.

Kreuzinger C, Geroldinger A, Smeets D, Braicu EI, Sehouli J, Koller J, Wolf A, Darb-Esfahani S, Joehrens K, Vergote I, Vanderstichele A, Boeckx B, Lambrechts D, Gabra H, Wisman GBA, Trillsch F, Heinze G, Horvat R, Polterauer S, Berns E, Theillet C, Cacsire Castillo-Tong D.

Clin Cancer Res. 2017 Dec 15;23(24):7621-7632. doi: 10.1158/1078-0432.CCR-17-1159. Epub 2017 Oct 2.


New cell line models for the development of personalized therapy for high grade serous ovarian cancer.

Castillo-Tong D, Von Der Decken I, Pfaffinger S, Wolf A, Kreuzinger C, Smeets D, Boeckx B, Lambrechts D, Singer C, Grimm C, Reinthaller A, Horvat R.

Ann Oncol. 2017 Oct;28 Suppl 7:vii15-vii16. doi: 10.1093/annonc/mdx511.005. No abstract available.


HPV prevalence in vulvar cancer in Austria.

Pils S, Gensthaler L, Alemany L, Horvat R, de Sanjosé S, Joura EA.

Wien Klin Wochenschr. 2017 Nov;129(21-22):805-809. doi: 10.1007/s00508-017-1255-2. Epub 2017 Sep 7.


Two different, mutually exclusively distributed, TP53 mutations in ovarian and peritoneal tumor tissues of a serous ovarian cancer patient: indicative for tumor origin?

Sukhbaatar N, Bachmayr-Heyda A, Auer K, Aust S, Deycmar S, Horvat R, Pils D.

Cold Spring Harb Mol Case Stud. 2017 Jul 5;3(4). pii: a001461. doi: 10.1101/mcs.a001461. Print 2017 Jul.


Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia.

Britt NS, Patel N, Shireman TI, El Atrouni WI, Horvat RT, Steed ME.

J Antimicrob Chemother. 2017 Feb;72(2):535-542. doi: 10.1093/jac/dkw453. Epub 2016 Dec 20.


Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer.

Auer K, Bachmayr-Heyda A, Sukhbaatar N, Aust S, Schmetterer KG, Meier SM, Gerner C, Grimm C, Horvat R, Pils D.

Oncotarget. 2016 Sep 20;7(38):61336-61354. doi: 10.18632/oncotarget.11038.


Vancomycin 24-Hour Area under the Curve/Minimum Bactericidal Concentration Ratio as a Novel Predictor of Mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia.

Britt NS, Patel N, Horvat RT, Steed ME.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):3070-5. doi: 10.1128/AAC.02714-15. Print 2016 May.


Anogenital Human Papillomavirus Prevalence is Unaffected by Therapeutic Tumour Necrosis Factor-alpha Inhibition.

Handisurya A, Lázár S, Papay P, Primas C, Haitel A, Horvat R, Tanew A, Vogelsang H, Kirnbauer R.

Acta Derm Venereol. 2016 May;96(4):494-8. doi: 10.2340/00015555-2298.


Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study.

Maritschnegg E, Wang Y, Pecha N, Horvat R, Van Nieuwenhuysen E, Vergote I, Heitz F, Sehouli J, Kinde I, Diaz LA Jr, Papadopoulos N, Kinzler KW, Vogelstein B, Speiser P, Zeillinger R.

J Clin Oncol. 2015 Dec 20;33(36):4293-300. doi: 10.1200/JCO.2015.61.3083. Epub 2015 Nov 9.


Gamma Interferon Assays Used in the Diagnosis of Tuberculosis.

Horvat RT.

Clin Vaccine Immunol. 2015 Aug;22(8):845-9. doi: 10.1128/CVI.00199-15. Epub 2015 May 27. Review.


Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome.

Auer K, Bachmayr-Heyda A, Aust S, Sukhbaatar N, Reiner AT, Grimm C, Horvat R, Zeillinger R, Pils D.

Oncotarget. 2015 Jul 10;6(19):17261-75.


Molecular characterization of 7 new established cell lines from high grade serous ovarian cancer.

Kreuzinger C, Gamperl M, Wolf A, Heinze G, Geroldinger A, Lambrechts D, Boeckx B, Smeets D, Horvat R, Aust S, Hamilton G, Zeillinger R, Cacsire Castillo-Tong D.

Cancer Lett. 2015 Jul 1;362(2):218-28. doi: 10.1016/j.canlet.2015.03.040. Epub 2015 Apr 8.


Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: A phase 2 study.

Tempfer CB, Winnekendonk G, Solass W, Horvat R, Giger-Pabst U, Zieren J, Rezniczek GA, Reymond MA.

Gynecol Oncol. 2015 May;137(2):223-8. doi: 10.1016/j.ygyno.2015.02.009. Epub 2015 Feb 18.


HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells.

Marhold M, Tomasich E, El-Gazzar A, Heller G, Spittler A, Horvat R, Krainer M, Horak P.

Mol Cancer Res. 2015 Mar;13(3):556-64. doi: 10.1158/1541-7786.MCR-14-0153-T. Epub 2014 Oct 27.


Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells.

Veigel D, Wagner R, Stübiger G, Wuczkowski M, Filipits M, Horvat R, Benhamú B, López-Rodríguez ML, Leisser A, Valent P, Grusch M, Hegardt FG, García J, Serra D, Auersperg N, Colomer R, Grunt TW.

Int J Cancer. 2015 May 1;136(9):2078-90. doi: 10.1002/ijc.29261. Epub 2014 Nov 3.


Aromatase Inhibitor Therapy As Effective Rescue in a Patient With Tamoxifen-Refractory Metastatic Granulosa Cell Tumor of the Ovary.

Lamm W, Schiefer A, Nöbauer IM, Horvat R, Speiser P, Köstler WJ.

J Clin Oncol. 2016 Feb 10;34(5):e31-3. doi: 10.1200/JCO.2013.49.5952. Epub 2014 Jun 16. No abstract available.


Ambivalent role of pFAK-Y397 in serous ovarian cancer--a study of the OVCAD consortium.

Aust S, Auer K, Bachmayr-Heyda A, Denkert C, Sehouli J, Braicu I, Mahner S, Lambrechts S, Vergote I, Grimm C, Horvat R, Castillo-Tong DC, Zeillinger R, Pils D.

Mol Cancer. 2014 Mar 21;13:67. doi: 10.1186/1476-4598-13-67.


TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo.

Horak P, Tomasich E, Vaňhara P, Kratochvílová K, Anees M, Marhold M, Lemberger CE, Gerschpacher M, Horvat R, Sibilia M, Pils D, Krainer M.

Sci Rep. 2014 Jan 17;4:3739. doi: 10.1038/srep03739.


High-level ERBB2 gene amplification is associated with a particularly short time-to-metastasis, but results in a high rate of complete response once trastuzumab-based therapy is offered in the metastatic setting.

Fuchs EM, Köstler WJ, Horvat R, Hudelist G, Kubista E, Attems J, Zielinski CC, Singer CF.

Int J Cancer. 2014 Jul 1;135(1):224-31. doi: 10.1002/ijc.28660. Epub 2014 Jan 28.


P16INK4A immunohistochemistry for detection of human papilloma virus-associated penile squamous cell carcinoma is superior to in-situ hybridization.

Aumayr K, Susani M, Horvat R, Wrba F, Mazal P, Klatte T, Koller A, Neudert B, Haitel A.

Int J Immunopathol Pharmacol. 2013 Jul-Sep;26(3):611-20.


Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortium.

Bachmayr-Heyda A, Aust S, Heinze G, Polterauer S, Grimm C, Braicu EI, Sehouli J, Lambrechts S, Vergote I, Mahner S, Pils D, Schuster E, Thalhammer T, Horvat R, Denkert C, Zeillinger R, Castillo-Tong DC.

BMC Cancer. 2013 Sep 17;13:422. doi: 10.1186/1471-2407-13-422.


Human papillomavirus in high-grade cervical lesions: Austrian data of a European multicentre study.

Rössler L, Reich O, Horvat R, de Souza SC, Holl K, Joura EA.

Wien Klin Wochenschr. 2013 Oct;125(19-20):591-9. doi: 10.1007/s00508-013-0403-6. Epub 2013 Sep 17.


HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer.

Lipton A, Goodman L, Leitzel K, Cook J, Sperinde J, Haddad M, Köstler WJ, Huang W, Weidler JM, Ali S, Newton A, Fuchs EM, Paquet A, Singer CF, Horvat R, Jin X, Banerjee J, Mukherjee A, Tan Y, Shi Y, Chenna A, Larson J, Lie Y, Sherwood T, Petropoulos CJ, Williams S, Winslow J, Parry G, Bates M.

Breast Cancer Res Treat. 2013 Aug;141(1):43-53.


Reply to "Mistaken identity of Brucella infection".

Horvat RT, El Atrouni W, Hammoud K, Hawkinson D, Cowden S.

J Clin Microbiol. 2013 Jun;51(6):2012. doi: 10.1128/JCM.00627-13. No abstract available.


Spread of endometriosis to pelvic sentinel lymph nodes: gene expression analysis.

Bürkle B, Notscheid NK, Scheich J, Hefler L, Tempfer CB, Horvat R, Rezniczek GA.

Eur J Obstet Gynecol Reprod Biol. 2013 Jul;169(2):370-5. doi: 10.1016/j.ejogrb.2013.03.029. Epub 2013 Apr 29.


Determination of tumor-infiltrating CD8+ lymphocytes in human ovarian cancer.

Aust S, Bachmayr-Heyda A, Pils D, Zhao L, Tong W, Berger A, Fogel M, Thalhammer T, Sehouli J, Horvat R, Zeillinger R, Castillo-Tong DC.

Int J Gynecol Pathol. 2013 May;32(3):269-76. doi: 10.1097/PGP.0b013e31826a63f8.


The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer.

Aust S, Horak P, Pils D, Pils S, Grimm C, Horvat R, Tong D, Schmid B, Speiser P, Reinthaller A, Polterauer S.

BMC Cancer. 2013 Mar 14;13:115. doi: 10.1186/1471-2407-13-115.


Expression of Bcl-2 and the antiapoptotic BAG family proteins in ovarian cancer.

Aust S, Pils S, Polterauer S, Horvat R, Cacsire Castillo-Tong D, Pils D, Dudek G, Schmid B, Speiser P, Reinthaller A, Grimm C.

Appl Immunohistochem Mol Morphol. 2013 Dec;21(6):518-24. doi: 10.1097/PAI.0b013e318284a053.


Delayed RSV diagnosis in a stem cell transplant population due to mutations that result in negative polymerase chain reaction.

Hawkinson D, Abhyankar S, Aljitawi O, Ganguly S, McGuirk JP, Horvat R.

Diagn Microbiol Infect Dis. 2013 Apr;75(4):426-30. doi: 10.1016/j.diagmicrobio.2012.12.014. Epub 2013 Feb 14.


Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -a study of the OVCAD consortium.

Aust S, Bachmayr-Heyda A, Pateisky P, Tong D, Darb-Esfahani S, Denkert C, Chekerov R, Sehouli J, Mahner S, Van Gorp T, Vergote I, Speiser P, Horvat R, Zeillinger R, Pils D.

Mol Cancer. 2012 Sep 14;11:69. doi: 10.1186/1476-4598-11-69.


Expression of BRAF V600E mutant protein in epithelial ovarian tumors.

Preusser M, Capper D, Berghoff AS, Horvat R, Wrba F, Schindl M, Schoppmann SF, von Deimling A, Birner P.

Appl Immunohistochem Mol Morphol. 2013 Mar;21(2):159-64. doi: 10.1097/PAI.0b013e31825d7402.


Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting.

Singer J, Weichselbaumer M, Stockner T, Mechtcheriakova D, Sobanov Y, Bajna E, Wrba F, Horvat R, Thalhammer JG, Willmann M, Jensen-Jarolim E.

Mol Immunol. 2012 Apr;50(4):200-9. doi: 10.1016/j.molimm.2012.01.002.


Impact of lifestyle factors on preneoplastic changes in prophylactic oophorectomies of BRCA mutation carriers.

Primas H, Kroiss R, Kalteis K, Rappaport C, Muhr D, Primas C, Kubista E, Horvat R, Oefner P, Singer C, Wagner And The Austrian Hereditary Breast And Ovarian Cancer Group T.

Eur J Cancer Prev. 2012 Mar;21(2):199-204. doi: 10.1097/CEJ.0b013e32834c9b22.


Relaxin and gonadal steroid receptors in uterosacral ligaments of women with and without pelvic organ prolapse.

Dietrich W, Elenskaia K, Obermayr E, Horvat R, Mayerhofer K, Umek W, Zeillinger R, Hanzal E.

Int Urogynecol J. 2012 Apr;23(4):495-500. doi: 10.1007/s00192-011-1615-9. Epub 2011 Nov 29.


hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancer.

Wittinger M, Vanhara P, El-Gazzar A, Savarese-Brenner B, Pils D, Anees M, Grunt TW, Sibilia M, Holcmann M, Horvat R, Schemper M, Zeillinger R, Schöfer C, Dolznig H, Horak P, Krainer M.

Clin Cancer Res. 2011 Dec 15;17(24):7816-27. doi: 10.1158/1078-0432.CCR-11-0408. Epub 2011 Oct 20.


Lymphatic spread of endometriosis to pelvic sentinel lymph nodes: a prospective clinical study.

Tempfer CB, Wenzl R, Horvat R, Grimm C, Polterauer S, Buerkle B, Reinthaller A, Huber JC.

Fertil Steril. 2011 Sep;96(3):692-6. doi: 10.1016/j.fertnstert.2011.06.070.


Recombinant human thyrotropin-aided radioiodine therapy in patients with metastatic differentiated thyroid carcinoma.

Zagar I, Schwarzbartl-Pevec AA, Vidergar-Kralj B, Horvat R, Besic N.

J Thyroid Res. 2012;2012:670180. doi: 10.1155/2012/670180. Epub 2011 Aug 18.


Demographics and microbiology of otorrhea through patent tubes failing ototopical and/or oral antibiotic therapy.

Fishman I, Sykes KJ, Horvat R, Selvarangan R, Newland J, Wei JL.

Otolaryngol Head Neck Surg. 2011 Dec;145(6):1025-9. doi: 10.1177/0194599811419098. Epub 2011 Aug 16.


The prognostic role of human papillomavirus in patients with vaginal cancer.

Brunner AH, Grimm C, Polterauer S, Hefler L, Stani J, Heinze G, Horvat R.

Int J Gynecol Cancer. 2011 Jul;21(5):923-9. doi: 10.1097/IGC.0b013e31821bc615.


Expression of hypoxia-associated proteins in sporadic medullary thyroid cancer is associated with desmoplastic stroma reaction and lymph node metastasis and may indicate somatic mutations in the VHL gene.

Koperek O, Bergner O, Pichlhöfer B, Oberndorfer F, Hainfellner JA, Kaserer K, Horvat R, Harris AL, Niederle B, Birner P.

J Pathol. 2011 Sep;225(1):63-72. doi: 10.1002/path.2926. Epub 2011 Jun 1.


European guidelines for quality assurance in cervical histopathology.

Bulten J, Horvat R, Jordan J, Herbert A, Wiener H, Arbyn M.

Acta Oncol. 2011 Jun;50(5):611-20. doi: 10.3109/0284186X.2011.555779. Epub 2011 Feb 11. Review.


Supplemental Content

Loading ...
Support Center